Roujun Peng

3.9k citations
48 papers · 1.4k indexed · h-index 18

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis

Papers in

    • Cancer Treatment and Pharmacology 7
    • HER2/EGFR in Cancer Research 7
    • Viral-associated cancers and disorders 3
    • Breast Cancer Treatment Studies 11
    • Cancer Genomics and Diagnostics 4

Roujun Peng

47 papers receiving 1.4k citations

Peers

Roujun Peng
Comparison fields: 5 of 96
  • Cancer Research 479
  • Oncology 781
  • Pathology and Forensic Medicine 388
  • Immunology 273
  • Genetics 129
Replace S Dirnhofer with:
S Dirnhofer Switzerland
Maria Monne Italy
David J. Byrne Australia
Paul J. van Diest Netherlands
Leah Prentice Canada
Gisele W. B. Colleoni Brazil
Thorunn Helgason United States
Kay Friedrichs Germany
Pierre Rudolph Germany
Bonnie L. King United States
Roujun Peng relative to S Dirnhofer Switzerland S Dirnhofer's profile →
Citations per field
00.5×3.2×
S Dirnhofer · 1×
Citations per year

Countries citing papers authored by Roujun Peng

Since Specialization
Citations

This map shows the geographic impact of Roujun Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roujun Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roujun Peng more than expected).

Fields of papers citing papers by Roujun Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roujun Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roujun Peng. The network helps show where Roujun Peng may publish in the future.

Co-authors

The 25 scholars most cited alongside Roujun Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roujun Peng Line = papers co-authored together Roujun Peng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014161
2 2015153
3 2011137
4 2016103
5 201475
6 201375
7 201174
8 201465
9 201956
10 201253
11 201349
12 201435
13 201233
14 201232
15 201130
16 201628
17 201528
18 201223
19 201816
20 201315

About Roujun Peng

Roujun Peng is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (8 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Cancer Genomics and Diagnostics (4 papers), Advanced Breast Cancer Therapies (4 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Cancer Research (479 citations), Oncology (781 citations), Pathology and Forensic Medicine (388 citations), Immunology (273 citations) and Genetics (129 citations). Roujun Peng has collaborated with scholars based in China, Sweden and Portugal. Frequent co-authors include Zhongyu Yuan, Shusen Wang, Tao Qin, Cong Xue, Rongzhen Luo, Xiaoyu Teng, Zhong-Yu Yuan, Shu-Sen Wang, Yanxia Shi and Yi‐Xin Zeng. Their work appears in journals such as Medical Oncology, Oncotarget, OncoTargets and Therapy, The Journal of Experimental Medicine and Chinese Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026